Israeli study identifies rare cochlear cells with potential to reverse hearing loss

Tel Aviv University researchers report that inhibiting Notch signaling can trigger a rare subset of cochlear supporting cells (transdifferentiating Deiters’ cells) to become hair cells, offering a potential path to regenerate hearing. Using live imaging and single-cell multi-omics, the team shows this regenerative capacity exists in humans and could be leveraged with inner-ear injections, though it remains early basic research. Translation to patients will require overcoming regulatory, cost, and safety hurdles, but the work marks a significant step toward treatments that restore hearing rather than simply aiding it.